Open Orphan plc is a European-focussed, rare and orphan drug consulting services platform. The Company consists of four elements: a European clinical research organisation and consultancy; an orphan drug services business; a Virtual Rep and Data Access Platform consisting of physicians and key opinion leaders; and a Health Data Platform to partner with Patient Advocacy Groups.
A presentation pack for Open Orphan plc was provided at our November Investor Forum. For more information, please contact: research@hardmanandco.com
If you'd like to be introduced to the team at Open Orphan, get in touch.
Request a meeting
